464 related articles for article (PubMed ID: 8675680)
1. The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle.
Kelley DE; Mintun MA; Watkins SC; Simoneau JA; Jadali F; Fredrickson A; Beattie J; Thériault R
J Clin Invest; 1996 Jun; 97(12):2705-13. PubMed ID: 8675680
[TBL] [Abstract][Full Text] [Related]
2. Abnormal glucose transport and GLUT1 cell-surface content in fibroblasts and skeletal muscle from NIDDM and obese subjects.
Miele C; Formisano P; Condorelli G; Caruso M; Oriente F; Andreozzi F; Tocchetti CG; Riccardi G; Beguinot F
Diabetologia; 1997 Apr; 40(4):421-9. PubMed ID: 9112019
[TBL] [Abstract][Full Text] [Related]
3. Insulin-induced hexokinase II expression is reduced in obesity and NIDDM.
Pendergrass M; Koval J; Vogt C; Yki-Jarvinen H; Iozzo P; Pipek R; Ardehali H; Printz R; Granner D; DeFronzo RA; Mandarino LJ
Diabetes; 1998 Mar; 47(3):387-94. PubMed ID: 9519744
[TBL] [Abstract][Full Text] [Related]
4. Regulation of skeletal muscle hexokinase II by insulin in nondiabetic and NIDDM subjects.
Kruszynska YT; Mulford MI; Baloga J; Yu JG; Olefsky JM
Diabetes; 1998 Jul; 47(7):1107-13. PubMed ID: 9648835
[TBL] [Abstract][Full Text] [Related]
5. Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity, IGT, GDM, and NIDDM.
Garvey WT; Maianu L; Hancock JA; Golichowski AM; Baron A
Diabetes; 1992 Apr; 41(4):465-75. PubMed ID: 1535055
[TBL] [Abstract][Full Text] [Related]
6. Glucose transport in cultured human skeletal muscle cells. Regulation by insulin and glucose in nondiabetic and non-insulin-dependent diabetes mellitus subjects.
Ciaraldi TP; Abrams L; Nikoulina S; Mudaliar S; Henry RR
J Clin Invest; 1995 Dec; 96(6):2820-7. PubMed ID: 8675652
[TBL] [Abstract][Full Text] [Related]
7. Pretranslational suppression of a glucose transporter protein causes insulin resistance in adipocytes from patients with non-insulin-dependent diabetes mellitus and obesity.
Garvey WT; Maianu L; Huecksteadt TP; Birnbaum MJ; Molina JM; Ciaraldi TP
J Clin Invest; 1991 Mar; 87(3):1072-81. PubMed ID: 1999488
[TBL] [Abstract][Full Text] [Related]
8. Insulin-stimulated Glut 4 translocation in human skeletal muscle: a quantitative confocal microscopical assessment.
Watkins SC; Frederickson A; Theriault R; Korytkowski M; Turner DS; Kelley DE
Histochem J; 1997 Feb; 29(2):91-6. PubMed ID: 9147065
[TBL] [Abstract][Full Text] [Related]
9. Interactions of impaired glucose transport and phosphorylation in skeletal muscle insulin resistance: a dose-response assessment using positron emission tomography.
Williams KV; Price JC; Kelley DE
Diabetes; 2001 Sep; 50(9):2069-79. PubMed ID: 11522673
[TBL] [Abstract][Full Text] [Related]
10. Muscle glucose transport and phosphorylation in type 2 diabetic, obese nondiabetic, and genetically predisposed individuals.
Pendergrass M; Bertoldo A; Bonadonna R; Nucci G; Mandarino L; Cobelli C; Defronzo RA
Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E92-100. PubMed ID: 16896161
[TBL] [Abstract][Full Text] [Related]
11. Insulin action on glucose transport and plasma membrane GLUT4 content in skeletal muscle from patients with NIDDM.
Zierath JR; He L; Gumà A; Odegoard Wahlström E; Klip A; Wallberg-Henriksson H
Diabetologia; 1996 Oct; 39(10):1180-9. PubMed ID: 8897005
[TBL] [Abstract][Full Text] [Related]
12. Restoration of insulin responsiveness in skeletal muscle of morbidly obese patients after weight loss. Effect on muscle glucose transport and glucose transporter GLUT4.
Friedman JE; Dohm GL; Leggett-Frazier N; Elton CW; Tapscott EB; Pories WP; Caro JF
J Clin Invest; 1992 Feb; 89(2):701-5. PubMed ID: 1737857
[TBL] [Abstract][Full Text] [Related]
13. Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM.
Simoneau JA; Kelley DE
J Appl Physiol (1985); 1997 Jul; 83(1):166-71. PubMed ID: 9216960
[TBL] [Abstract][Full Text] [Related]
14. Insulin action kinetics in adipocytes from obese and noninsulin-dependent diabetes mellitus subjects: identification of multiple cellular defects in glucose transport.
Ciaraldi TP; Molina JM; Olefsky JM
J Clin Endocrinol Metab; 1991 Apr; 72(4):876-82. PubMed ID: 2005215
[TBL] [Abstract][Full Text] [Related]
15. Studies of gene expression and activity of hexokinase, phosphofructokinase and glycogen synthase in human skeletal muscle in states of altered insulin-stimulated glucose metabolism.
Vestergaard H
Dan Med Bull; 1999 Feb; 46(1):13-34. PubMed ID: 10081651
[TBL] [Abstract][Full Text] [Related]
16. Oxidative stress--mediated alterations in glucose dynamics in a genetic animal model of type II diabetes.
Bitar MS; Al-Saleh E; Al-Mulla F
Life Sci; 2005 Sep; 77(20):2552-73. PubMed ID: 15936776
[TBL] [Abstract][Full Text] [Related]
17. Obesity, type 2 diabetes, and impaired insulin-stimulated blood flow: role of skeletal muscle NO synthase and endothelin-1.
Reynolds LJ; Credeur DP; Manrique C; Padilla J; Fadel PJ; Thyfault JP
J Appl Physiol (1985); 2017 Jan; 122(1):38-47. PubMed ID: 27789766
[TBL] [Abstract][Full Text] [Related]
18. Glucose uptake and GLUT-4 protein distribution in skeletal muscle of the obese Zucker rat.
Brozinick JT; Etgen GJ; Yaspelkis BB; Ivy JL
Am J Physiol; 1994 Jul; 267(1 Pt 2):R236-43. PubMed ID: 8048627
[TBL] [Abstract][Full Text] [Related]
19. Glucose transport and phosphorylation in skeletal muscle in obesity: insight from a muscle-specific positron emission tomography model.
Williams KV; Bertoldo A; Mattioni B; Price JC; Cobelli C; Kelley DE
J Clin Endocrinol Metab; 2003 Mar; 88(3):1271-9. PubMed ID: 12629118
[TBL] [Abstract][Full Text] [Related]
20. Skeletal muscle peroxisome proliferator- activated receptor-gamma expression in obesity and non- insulin-dependent diabetes mellitus.
Kruszynska YT; Mukherjee R; Jow L; Dana S; Paterniti JR; Olefsky JM
J Clin Invest; 1998 Feb; 101(3):543-8. PubMed ID: 9449686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
